(Q46447497)

English

Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

L Dirven

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

K Visser

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

N B Klarenbeek

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

J A P M Ewals

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

K H Han

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

A J Peeters

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

P J S M Kerstens

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

T W J Huizinga

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

B A C Dijkmans

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

C F Allaart

10

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

publication date

21 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

Scandinavian Journal of Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

41

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

15-19

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.594964

21 January 2018

A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.594964

21 January 2018

Work ability: a new outcome measure in rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.594964

21 January 2018

Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.594964

21 January 2018

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.594964

21 January 2018

Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.594964

21 January 2018

Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.594964

21 January 2018

Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.594964

21 January 2018

Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.594964

21 January 2018

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2011.594964

21 January 2018

Identifiers

10.3109/03009742.2011.594964

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22103436

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46447497&oldid=2112014176"